Colony Group LLC Gilead Sciences, Inc. Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Colony Group LLC holds 55,632 shares of GILD stock, worth $5.18 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

55,632

Previous 56,816 2.08%

Holding current value

$5.18 Million

Previous $4.38 Million 4.8%

% of portfolio

0.06%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $87,544 - $95,513	-1,184 Reduced 2.08%	55,632 $4.17 Million
Q2 2023 Aug 15, 2023	BUY	$76.01 - $86.7 $9,349 - $10,664	123 Added 0.22%	56,816 $4.38 Million
Q1 2023 May 16, 2023	SELL	$77.31 - $88.08 $603,636 - $687,728	-7,808 Reduced 12.11%	56,693 $4.7 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $132,430 - $190,123	2,125 Added 3.41%	64,501 $5.54 Million
Q3 2022 Nov 15, 2022	SELL	$59.54 - $68.01 $165,223 - $188,727	-2,775 Reduced 4.26%	62,376 $3.85 Million
Q2 2022 Aug 16, 2022	SELL	$57.72 - $65.01 $1.34 Million - $1.5 Million	-23,135 Reduced 26.2%	65,151 $4.03 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $2.32 Million - $2.9 Million	40,017 Added 82.9%	88,286 $5.25 Million
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $2.44 Million - $2.77 Million	-37,597 Reduced 43.79%	48,269 $3.51 Million
Q3 2021 Nov 17, 2021	BUY	$67.69 - $73.03 $4.77 Million - $5.15 Million	70,515 Added 459.35%	85,866 $6 Million
Q2 2021 Aug 18, 2021	SELL	$63.47 - $69.35 $2.9 Million - $3.16 Million	-45,630 Reduced 74.83%	15,351 $1.06 Million
Q1 2021 May 21, 2021	BUY	$60.0 - $68.46 $308,160 - $351,610	5,136 Added 9.2%	60,981 $3.94 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $194,706 - $221,858	-3,437 Reduced 5.8%	55,845 $3.25 Million
Q3 2020 Nov 17, 2020	BUY	$62.1 - $78.08 $115,319 - $144,994	1,857 Added 3.23%	59,282 $3.75 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $264,185 - $306,768	-3,652 Reduced 5.98%	57,425 $4.42 Million
Q1 2020 May 18, 2020	SELL	$62.63 - $80.22 $40,772 - $52,223	-651 Reduced 1.05%	61,077 $4.57 Million
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $296,268 - $325,886	-4,808 Reduced 7.23%	61,728 $4.01 Million
Q3 2019 Nov 26, 2019	BUY	$62.51 - $69.0 $188,655 - $208,242	3,018 Added 4.75%	66,536 $4.22 Million
Q2 2019 Aug 19, 2019	BUY	$61.87 - $69.38 $3.66 Million - $4.11 Million	59,217 Added 1376.82%	63,518 $4.29 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $268,941 - $301,285	4,301 New	4,301 $280,000
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $254,389 - $331,958	-4,202 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $49,254 - $54,533	691 Added 19.68%	4,202 $324,000
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $24,330 - $28,380	-375 Reduced 9.65%	3,511 $249,000
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $75,607 - $92,174	1,038 Added 36.45%	3,886 $293,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $8,893 - $10,440	125 Added 4.59%	2,848 $204,000
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $196,355 - $232,734	2,723	2,723 $221,000

Others Institutions Holding GILD

# of Institutions

1,942

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account